Dr. Thomas Seyfried and Dr. Dominic D’Agostino are prominent voices advocating for a paradigm shift in understanding cancer—not as primarily a genetic disease, but as a metabolic disorder rooted in mitochondrial dysfunction. Their collaborative work builds on Otto Warburg’s early 20th-century observation that cancer cells favor fermentation (glycolysis) for energy production, even in the presence of
